KRAS and squamous cell carcinoma: In the literature, there is a hypothesis that the activation of the KRAS pathway may occur in squamous cell carcinomas by the action of the KRAS-LCS6 normal variant, which may therefore be associated with the susceptibility and clinical outcome of cancer (10).